To see the effect of Shatpushpa taila Nasya and Shatpushpa Taila Matrabasti with Tilamooladi churan in the management of Pushpaghni wsr to Polycystic Ovarian Syndrome

A comparative study of shatpushpa taila (nasya and matrabasti) along with tilamooladi churan in the managment of pushpaghni wsr to polycystic ovarian syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027436

Enrollment

Registered

2020-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Shatpushpa taila Nasya along with Tilamooladi churna: Shatpushpa taila Nasya 2 drops in each nostril once a day and Tilamooladi churna 5g twice a day for 7 days Control Intervention1: S

Eligibility

Inclusion criteria

Inclusion criteria: Fullfill at least 2 of the following:- 1.Oligomenorrhea and/or anovulation 2.Hyperandonism (Clinical and/or bio-chemical) 3.PCOS-Diagnosed by Trans Vaginal Sonography (TVS In married)and USG Abdomen in unmarried.

Exclusion criteria

Exclusion criteria: •Any other cause of oligomenorrhea and anovulation excluding PCOD. •Any organic lesion like adrenal or ovarian. •Congenital anomalies and any other pelvic pathology. •Patients having STDs

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of patients Oligomenorrhea,Hypomenorrhea, Dysmenorrhoea,Menorrhagia Timepoint: 2 months	—

Secondary

Measure	Time frame
Efficacy of the medicine on Obesity,Acne, HirsutismTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Rashmi Sharma

University College of Ayurveda,DSRRAU Jodhpur

vd_rashmi11@yahoo.com9166607559

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026